Search research articles
Contact Us
Filters
Showing results (231-240 of 382) with videos related to
Page
of 39
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
May 29, 2014
[Cardiac resynchronization therapy in heart failure--Norwegian guidelines]
Torbjørn Holm, Svein Færestrand, Alf Inge Larsen, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
European Journal of Heart Failure
|
March 29, 2006
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study
Dirk J van Veldhuisen, Halfdan Aass, Dia El Allaf, et al.
European Journal of Applied Physiology
|
August 14, 2019
Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise
Sissel Nygaard, Anders Haugom Christensen, Katrine Rolid, et al.
ESC Heart Failure
|
August 27, 2018
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
Thor Ueland, Lars Gullestad, Lei Kou, et al.
Transplantation
|
March 3, 2022
Predictors of Hypertension Development 1 Year After Heart Transplantation
Sissel Nygaard, Anders H Christensen, Line Sletner, et al.
Journal of the American College of Cardiology
|
May 14, 2003
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
Torgun Waehre, Jan K Damås, Lars Gullestad, et al.
Thrombosis and Haemostasis
|
October 7, 2009
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Wiggo J Sandberg, Kari Otterdal, Lars Gullestad, et al.
Journal of the American College of Cardiology
|
July 21, 2004
Potential anti-inflammatory role of activin A in acute coronary syndromes
Camilla Smith, Arne Yndestad, Bente Halvorsen, et al.
Atherosclerosis
|
January 22, 2026
Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure
Thor Ueland, Geir Øystein Andersen, Sharanga Varathalingam, et al.
Page
of 39
Search research articles
Search
Showing results (231-240 of 382) with videos related to
Sort By:
Page
of 39
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
May 29, 2014
[Cardiac resynchronization therapy in heart failure--Norwegian guidelines]
Torbjørn Holm, Svein Færestrand, Alf Inge Larsen, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
European Journal of Heart Failure
|
March 29, 2006
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study
Dirk J van Veldhuisen, Halfdan Aass, Dia El Allaf, et al.
European Journal of Applied Physiology
|
August 14, 2019
Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise
Sissel Nygaard, Anders Haugom Christensen, Katrine Rolid, et al.
ESC Heart Failure
|
August 27, 2018
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
Thor Ueland, Lars Gullestad, Lei Kou, et al.
Transplantation
|
March 3, 2022
Predictors of Hypertension Development 1 Year After Heart Transplantation
Sissel Nygaard, Anders H Christensen, Line Sletner, et al.
Journal of the American College of Cardiology
|
May 14, 2003
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
Torgun Waehre, Jan K Damås, Lars Gullestad, et al.
Thrombosis and Haemostasis
|
October 7, 2009
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Wiggo J Sandberg, Kari Otterdal, Lars Gullestad, et al.
Journal of the American College of Cardiology
|
July 21, 2004
Potential anti-inflammatory role of activin A in acute coronary syndromes
Camilla Smith, Arne Yndestad, Bente Halvorsen, et al.
Atherosclerosis
|
January 22, 2026
Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure
Thor Ueland, Geir Øystein Andersen, Sharanga Varathalingam, et al.
Page
of 39